To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer

NCT02846428 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: 5-Fluorouracil
DRUG: Capecitabine
DRUG: Cyclophosphamide
DRUG: Docetaxel
DRUG: Epirubicin

Sponsor

Hoffmann-La Roche